Evidence map›Paper›PMID 34473814›Full record

ArticlePLoS pathogens2021

The opportunistic intracellular bacterial pathogen Rhodococcus equi elicits type I interferon by engaging cytosolic DNA sensing in macrophages.

Krystal J Vail, Bibiana Petri da Silveira, Samantha L Bell, Noah D Cohen, Angela I Bordin, Kristin L Patrick, Robert O Watson

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Antimicrobial Resistance inAntibiotics (Basel, Switzerland) · 2026
    Review
  3. bioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Review
  6. Integrated molecular and serological survey ofFrontiers in veterinary science · 2025
    Article
  7. IntratumorCurrent research in microbial sciences · 2025
    Article
  8. Cold and hot tumors: from molecular mechanisms to targeted therapy.Signal transduction and targeted therapy · 2024
    Review
  9. Review
  10. Seasonal Changes in the Microbial Communities on Lettuce (Journal of microbiology and biotechnology · 2023
    Article
  11. International journal of molecular sciences · 2022
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Krystal J VailDepartment of Microbial Pathogenesis and Immunology, Texas A&M Health Science Center, Bryan, Texas, United States of America.ORCID 0000-0002-1964-7985
Bibiana Petri da SilveiraDepartment of Large Animal Clinical Sciences, Texas A&M University, College Station, Texas, United States of America.ORCID 0000-0002-5588-2851
Samantha L BellDepartment of Microbial Pathogenesis and Immunology, Texas A&M Health Science Center, Bryan, Texas, United States of America.ORCID 0000-0002-5453-3203
Noah D CohenDepartment of Large Animal Clinical Sciences, Texas A&M University, College Station, Texas, United States of America.ORCID 0000-0002-0384-2903
Angela I BordinDepartment of Large Animal Clinical Sciences, Texas A&M University, College Station, Texas, United States of America.ORCID 0000-0002-7678-3908
Kristin L PatrickDepartment of Microbial Pathogenesis and Immunology, Texas A&M Health Science Center, Bryan, Texas, United States of America.
Robert O WatsonDepartment of Microbial Pathogenesis and Immunology, Texas A&M Health Science Center, Bryan, Texas, United States of America.ORCID 0000-0003-4976-0759
Texas A&M Health Science Center · USTexas A&M University · US

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
Comparative Biomedical Research Training for VeterinariansT32OD011083 · OD · TEXAS A&M AGRILIFE RESEARCH · PI ALBERT MULENGA · 2012 to 2026
$4.8M
Mitochondria as crucial regulators of innate immune outcomes during Mycobacterium tuberculosis infectionR01AI155621 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PATRICK, KRISTIN LEIGH, WATSON, ROBERT OWEN · 2021 to 2025
$2.9M
TRIM proteins polarize DNA sensing outcomes during the innate immune response to Mycobacterium tuberculosisR01AI125512 · NIAID · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI WATSON, ROBERT OWEN · 2016 to 2019
$1.5M
NIAID NIH HHS R01 AI125512NIAID NIH HHS R01 AI155621NIH HHS P51 OD011104NIH HHS T32 OD011083
6 · The paper itself

Abstract

Rhodococcus equi is a major cause of foal pneumonia and an opportunistic pathogen in immunocompromised humans. While alveolar macrophages constitute the primary replicative niche for R. equi, little is known about how intracellular R. equi is sensed by macrophages. Here, we discovered that in addition to previously characterized pro-inflammatory cytokines (e.g., Tnfa, Il6, Il1b), macrophages infected with R. equi induce a robust type I IFN response, including Ifnb and interferon-stimulated genes (ISGs), similar to the evolutionarily related pathogen, Mycobacterium tuberculosis. Follow up studies using a combination of mammalian and bacterial genetics demonstrated that induction of this type I IFN expression program is largely dependent on the cGAS/STING/TBK1 axis of the cytosolic DNA sensing pathway, suggesting that R. equi perturbs the phagosomal membrane and causes DNA release into the cytosol following phagocytosis. Consistent with this, we found that a population of ~12% of R. equi phagosomes recruits the galectin-3,-8 and -9 danger receptors. Interestingly, neither phagosomal damage nor induction of type I IFN require the R. equi's virulence-associated plasmid. Importantly, R. equi infection of both mice and foals stimulates ISG expression, in organs (mice) and circulating monocytes (foals). By demonstrating that R. equi activates cytosolic DNA sensing in macrophages and elicits type I IFN responses in animal models, our work provides novel insights into how R. equi engages the innate immune system and furthers our understanding how this zoonotic pathogen causes inflammation and disease.

Indexed as

Actinomycetales InfectionsAnimalsCytosolDNAFemaleHorse DiseasesHorsesImmunity, InnateInterferon Type IMacrophagesMaleMiceRhodococcus equiDNAInterferon Type I

Identifiers

PMID34473814
PMCPMC8443056
OpenAlexW3198617697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.